An Open-Label Study to Assess the Effect of Dexpramipexole (BIIB050) on the Pharmacokinetics of Warfarin in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2014
At a glance
- Drugs Dexpramipexole (Primary) ; Warfarin
- Indications Amyotrophic lateral sclerosis; Thrombosis
- Focus Pharmacokinetics
- Sponsors Knopp Biosciences
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 May 2012 Actual initiation date (May 2012) added as reported by ClinicalTrials.gov.
- 24 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.